Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Arnica montana + Bellis perennis (homeopathic)
- Development stage
- Phase 3
- Lead developer
- Shaare Zedek Medical Center
- Administration
- Oral
01
Overview
This homeopathic combination consists of highly diluted preparations of *Arnica montana* (Leopard's bane) and *Bellis perennis* (common daisy). It was evaluated in a clinical trial at Shaare Zedek Medical Center for its potential to reduce blood loss during the third stage of delivery (postpartum hemorrhage). In homeopathic tradition, these agents are used for their anti-hemorrhagic and analgesic properties following physical trauma. The clinical research compared two different potencies (C6 and C30) against a placebo to assess their impact on hemoglobin levels and overall blood loss in postpartum women.
- Other names
- Arnica montana C6Bellis perennis C6Arnica montana C30Bellis perennis C30
Beyond the preview
Go deeper on Arnica montana + Bellis perennis (homeopathic).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Arnica montana + Bellis perennis (homeopathic).